Jennifer Kayden Lee is VP at RHYTHM PHARMACEUTICALS, INC. (RYTM). They have made 5 open-market trades across 1 company since 2023, most recently 2026-08-13.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RYTM | 75,834 | $6.5M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RYTM | SELL · 10b5-1 | 2026-08-13 | 2026-08-14 | $117.38 | $8.9M | -3.6% | -11.7% | — |
| RYTM | SELL · 10b5-1 | 2025-02-19 | 2025-02-19 | $57.22 | $233K | -9.4% | -10.0% | +10.5% |
| RYTM | SELL · 10b5-1 | 2025-02-12 | 2025-02-14 | $56.85 | $240K | -6.3% | -7.5% | +6.3% |
| RYTM | SELL · 10b5-1 | 2025-02-10 | 2025-02-11 | $58.64 | $611K | -3.1% | -10.9% | +4.6% |
| RYTM | SELL · 10b5-1 | 2025-02-05 | 2025-02-07 | $60.50 | $359K | -2.7% | -18.2% | +2.3% |
| RYTM | SELL | 2025-02-04 | 2025-02-04 | $59.43 | $172K | -6.2% | -14.5% | +6.6% |
| RYTM | SELL · 10b5-1 | 2024-11-11 | 2024-11-13 | $66.24 | $7.7M | +0.3% | -7.5% | -3.6% |
| RYTM | SELL | 2024-03-20 | 2024-03-22 | $38.77 | $1.4M | -0.7% | -3.4% | +0.7% |
| RYTM | SELL | 2024-03-19 | 2024-03-19 | $39.22 | $1.2M | +9.9% | -1.9% | +6.0% |
| RYTM | SELL | 2024-02-12 | 2024-02-13 | $51.02 | $136K | -7.7% | -20.0% | -19.6% |
| RYTM | SELL | 2024-02-01 | 2024-02-05 | $45.06 | $134K | +10.0% | -10.5% | -4.4% |
| RYTM | SELL · 10b5-1 | 2023-11-14 | 2023-11-16 | $32.01 | $876K | -1.2% | +36.5% | +52.5% |
| RYTM | SELL · 10b5-1 | 2023-11-08 | 2023-11-13 | $28.62 | $425K | +15.6% | +38.9% | +75.0% |
| RYTM | SELL · 10b5-1 | 2023-11-03 | 2023-11-07 | $28.00 | $2K | +21.0% | +36.0% | +64.6% |
| RYTM | SELL · 10b5-1 | 2023-09-05 | 2023-09-07 | $28.05 | $346K | -5.7% | -7.4% | +47.2% |
| RYTM | SELL · 10b5-1 | 2023-08-07 | 2023-08-09 | $24.21 | $585K | +2.3% | -1.3% | +6.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.